Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy – A Brazilian health care referral center cohort study

OBJECTIVE: Pregnant women with type 1 diabetes (T1D) have an increased risk of maternal-fetal complications. Regarding treatment, continuous subcutaneous insulin infusion (CSII) has advantages compared to multiple daily injections (MDI), but data about the best option during pregnancy are limited. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogassavara, Juliana, Dualib, Patricia Medici, Mattar, Rosiane, Dib, Sérgio Atala, de Almeida-Pititto, Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660998/
https://www.ncbi.nlm.nih.gov/pubmed/37364140
http://dx.doi.org/10.20945/2359-4292-2022-0483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660998/
https://www.ncbi.nlm.nih.gov/pubmed/37364140
http://dx.doi.org/10.20945/2359-4292-2022-0483

Ejemplares similares